▮ More

B. Riley Financial Inc. Q3 Earnings Summary

By RTTNews Staff Writer ✉ | Published: 11/8/2023 8:44 AM ET |

Below are the earnings highlights for B. Riley Financial Inc. (RILY):

Earnings: -$75.838 million in Q3 vs. $45.835 million in the same period last year.
EPS: -$2.53 in Q3 vs. $1.53 in the same period last year.
Revenue: $462.312 million in Q3 vs. $312.117 million in the same period last year.

For comments and feedback contact: editorial@rttnews.com

Biotech Stocks Facing FDA Decision In April 2024

Biotech Stocks Facing FDA Decision in March 2024

Biotech Stocks Facing FDA Decision In November 2023

Western Mixers Recalls Yogurt Covered Pretzels

Novartis' Scemblix Gets Breakthrough Designation For Chronic CML

CPSC Recalls: UTVs, Snowmobiles, Wall Ovens, Chairs, Toy Pinwheels, Nightgowns

Texas Pecan Recalls Select Nuts, Snack Mixes, Seeds, Snack Sticks

GM To End Chevy Malibu Production

Uber Q1 Net Loss Sharply Widens, Misses Estimates

AstraZeneca To Withdraw Its Covid-19 Vaccine Vaxzevria Worldwide

Novavax Stock More Than Doubles On Deal With Sanofi To Co-commercialize Covid-19 Vaccine

Shopify Tanks 19% On Gross Margin Outlook

Constellation Energy Reaffirms FY24 Operating Earnings Outlook - Update

SAIC Secures $232 Mln U.S. Army Contract To Develop Electronic Warfare Systems

B. Riley Financial Inc. Q3 Earnings Summary

Western Mixers Recalls Yogurt Covered Pretzels

Novartis' Scemblix Gets Breakthrough Designation For Chronic CML

CPSC Recalls: UTVs, Snowmobiles, Wall Ovens, Chairs, Toy Pinwheels, Nightgowns

Texas Pecan Recalls Select Nuts, Snack Mixes, Seeds, Snack Sticks

GM To End Chevy Malibu Production

Uber Q1 Net Loss Sharply Widens, Misses Estimates

AstraZeneca To Withdraw Its Covid-19 Vaccine Vaxzevria Worldwide

Novavax Stock More Than Doubles On Deal With Sanofi To Co-commercialize Covid-19 Vaccine

Shopify Tanks 19% On Gross Margin Outlook

Constellation Energy Reaffirms FY24 Operating Earnings Outlook - Update

SAIC Secures $232 Mln U.S. Army Contract To Develop Electronic Warfare Systems

Mitsubishi Motors FY23 Net Profit Down; Sees Weak Profit, Higher Sales In FY24

Merck's Phase 3 Trial Of KEYTRUDA Plus Chemotherapy In Endometrial Cancer Fails To Meet Primary Goal

AstraZeneca To Withdraw Its Covid-19 Vaccine Vaxzevria Worldwide

Novavax Q1 Loss Narrows, Beats Estimates; Revises Down Annual Revenue Guidance Below View - Update

Novartis' Scemblix Gets Breakthrough Designation For Chronic CML

TELUS Corporation Q1 Profit Down; Sets Dividend - Update

Merck' Keytruda Receives Approval From Health Canada For Biliary Tract Carcinoma In Adults

Viatris Inc. Q1 Profit Drops, Inline With Estimates

SBM Offshore Q1 Directional Revenue Up 17% - Quick Facts

John Wood Group Q1 Adj. EBITDA Rises, Revenues Down; Confirms FY24, FY25 Guidance

Workspace Group Names Lawrence Hutchings CEO Designate

Western Mixers Recalls Yogurt Covered Pretzels

MKS Instruments Inc. Q1 Earnings Summary

LifeStance Health Group, Inc. Q2 Loss Decreases, Beats Estimates

ZEEKR Intelligent Announces IPO Of 21 Mln ADSs At $21/ADS

CleanSpark Appoints Scott Garrison As COO And Taylor Monnig As CTO

RumbleOn Posts Narrower Loss From Cont. Ops. In Q1

Microsoft To Invest $3.3 Bln To Accelerate Wisconsin's AI Infrastructure, Economic Growth

OppFi Inc. Q1 Profit Rises, Beats Estimates; Lifts Annual EPS Above View - Update

AstraZeneca To Withdraw Its Covid-19 Vaccine Vaxzevria Worldwide